KOSDAQ Robotics and Bio Stocks Gain Ground Despite Broader Market Dip

The Korean markets faced downward pressure during the morning session, with the KOSPI falling 1.43% to 6,950.76 and the KOSDAQ dropping 1.44% to 818.39. The USD/KRW exchange rate hovered at 1,340.86, reflecting a cautious trading sentiment. Despite the broader market decline, select robotics and biotech shares on the KOSDAQ managed to post notable gains.

ROBOTIS (108490) +6.13%

ROBOTIS surged 6.13% driven by strong performance expectations for its core components, with its actuator order backlog surpassing 500,000 units and anticipated supply growth to Hugging Face [2][5]. Positive market sentiment was bolstered by simultaneous net buying from foreign and institutional investors, alongside a fully sold-out 100 billion KRW block deal to foreign institutions [3][6]. Additionally, a favorable brokerage report stating "ROBOTIS competes with ROBOTIS" supported the stock's strength [1]. However, the exact reasons behind its rapid month-long rise from 180,000 to 330,000 KRW remain unconfirmed from the headlines alone [4].

PenetriumBio (187660) +9.57%

PenetriumBio climbed 9.57%, following a previous session on September 9 where it hit the daily upper limit of 29.95% to close at 7,420 KRW, triggering two volatility interruptions (VI) [8][10][12]. Despite this dramatic upward momentum, the specific underlying drivers or fundamental reasons behind this sudden surge remain completely unconfirmed, with media reports raising questions rather than providing concrete explanations [11]. Consequently, the core catalyst for the stock's recent movements cannot be verified solely from the provided headlines [7][9].

SPG CO., LTD (058610) +6.22%

SPG CO., LTD gained 6.22%, likely supported by its announcement of an interim dividend of 100 KRW per common share, totaling approximately 2.22 billion KRW [14]. Although the stock experienced a brief intraday dip of 0.85% to 93,400 KRW on September 7 [13], it rebounded strongly. However, the specific additional drivers behind its final positive performance and recovery are unconfirmed based on the provided headlines alone.

Sources

1. 로보티즈, '로보티즈는 로보티즈와 경쟁한다' 증권사 발표에 강세 — 매일경제 마켓 · 2026-09-10
2. "액추에이터 수주잔고 50만대 이상"…로보티즈 주가 5% 급등 — 한국경제 · 2026-09-10
3. [장중수급포착] 로보티즈, 외국인/기관 동시 순매수… 주가 +8.80% — 뉴스핌 · 2026-09-09
4. 한달새 18만→33만원…로보티즈, 오늘 또 5% 뛴 이유 — 한국경제 · 2026-09-07
5. 한투증권 "로보티즈, 허깅페이스향 액추에이터 공급 증가 예상" — 연합뉴스 · 2026-09-09
6. 로보티즈 1000억 블록딜, 외국계 2곳이 받았다…'클럽딜'로 완판 [fn마켓워치] — v.daum.net · 2026-09-08
7. [주가] 9월 9일 주요 제약·바이오·기기 5% 변동 현황 - 페니트리움바이오 상한가 — 메디파나뉴스 · 2026-09-09
8. [속보] 페니트리움바이오 주가 상한가 도달…VI 두 차례 발동 — CBC뉴스 · 2026-09-09
9. 페니트리움바이오, 상한가 진입.. +29.95% ↑ — sedaily.com · 2026-09-09
10. 페니트리움바이오 주가, 9월 9일 상한가 7,420원 29.95% 상승 마감 — 중앙이코노미뉴스 · 2026-09-09
11. 페니트리움바이오 주가, 상한가... 왜? — 금강일보 · 2026-09-09
12. 페니트리움바이오 주가, 9월 9일 7,420원 29.95% 상승 마감 — 톱스타뉴스 · 2026-09-09
13. 에스피지 주가, 9월 7일 장중 93,400원 0.85% 하락 — 톱스타뉴스 · 2026-09-07
14. 에스피지, 중간배당 결정…보통주 1주당 100원·총 22억1774만원 — 디지털투데이 · 2026-09-07

This is market commentary, not investment advice.